Therapeutic Peptides and Proteins: Formulation, Processing, and Delivery Systems, Third Edition | Agenda Bookshop Skip to content
Selected Colleen Hoover Books at €9.99c | In-store & Online
Selected Colleen Hoover Books at €9.99c | In-store & Online
A01=Ajay K. Banga
Age Group_Uncategorized
Age Group_Uncategorized
Author_Ajay K. Banga
automatic-update
Category1=Non-Fiction
Category=PSD
Category=TCB
Category=TDCW
COP=United States
Delivery_Pre-order
Language_English
PA=Temporarily unavailable
Price_€100 and above
PS=Active
softlaunch

Therapeutic Peptides and Proteins: Formulation, Processing, and Delivery Systems, Third Edition

English

By (author): Ajay K. Banga

There are more than 500 biopharmaceuticals on the market, including more than 200 therapeutic proteins, making biologics the fastest growing sector in the biopharmaceutical market. These products include more than 40 monoclonal antibodies, for indications ranging from treatment or mitigation of various types of cancer to rheumatoid arthritis.

The clinical application of these therapeutic peptides and proteins is limited by several problems, such as lack of physical and chemical stability or the lack of desirable attributes for adequate absorption or distribution. Thus, as these therapeutic peptides and proteins are made available, it will be essential to formulate these drugs into safe, stable, and efficacious delivery systems. The pharmaceutical scientist involved in this effort needs to call upon the knowledge of several disciplines, such as pharmaceutics, medicinal chemistry, biochemistry, microbiology, and chemical engineering and needs to keep abreast with the latest research in the published literature.

Therapeutic Peptides and Proteins: Formulation, Processing, and Delivery Systems, Third Edition provides a comprehensive overview of the field for scientists in industry and academia and for students, while also providing practical information on the challenges facing the formulation and delivery aspects of these unique macromolecules. In particular, the book:

  • Explains how recombinant DNA techniques now allow us to produce therapeutic proteins in a commercially viable form
  • Discusses the physical and chemical pathways of peptide and protein degradation
  • Includes a detailed discussion of protein formulation and lyophilization
  • Overviews the pharmacokinetic aspects of therapeutic peptides and proteins and discusses controlled delivery systems for parenteral administration, including microsphere formulations
  • Discusses research progress on oral, transdermal, mucosal, and topical delivery systems discusses transdermal and topical delivery
See more
Current price €184.29
Original price €193.99
Save 5%
A01=Ajay K. BangaAge Group_UncategorizedAuthor_Ajay K. Bangaautomatic-updateCategory1=Non-FictionCategory=PSDCategory=TCBCategory=TDCWCOP=United StatesDelivery_Pre-orderLanguage_EnglishPA=Temporarily unavailablePrice_€100 and abovePS=Activesoftlaunch

Will deliver when available.

Product Details
  • Weight: 900g
  • Dimensions: 156 x 234mm
  • Publication Date: 23 Apr 2015
  • Publisher: Taylor & Francis Inc
  • Publication City/Country: United States
  • Language: English
  • ISBN13: 9781466566064

About Ajay K. Banga

Ajay K. Banga is a professor and chair of the Department of Pharmaceutical Sciences at the College of Pharmacy and Health Sciences Mercer University Atlanta Georgia. He obtained a PhD in pharmaceutics from Rutgers University New Jersey. Dr. Banga is currently a major advisor to eight PhD students. He currently serves on the editorial board of eight journals and has also served as the Editor-in-Chief for one drug delivery journal. He has served on over 30 thesis/dissertation advisory committees and as a referee for more than 28 journals. Dr. Banga is a fellow of the American Association of Pharmaceutical Scientists. He has written more than 220 publications and scientific abstracts.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept